Covalon Technologies Ltd.

MISSISSAUGA, A6 · Medtech · Public

Advanced medical coatings and wound care devices with antimicrobial and biocompatible properties

New patent ·
Claim this profile

Follows are private to you and power your alerts

Updated · covalon.com

Sector
Medtech
Headquarters
MISSISSAUGA, A6
Latest Form D
$331K, Sep 2019
Total capital
$331K
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$331K
1 Form D · last Sep 2019
85 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
3
4 pending · first 2024
Rank in peer group#370 of 1112

Capital timeline

2019FEDERAL ↑EQUITY ↓Cumulative $331K1st Form D$331K
2019FEDERAL ↑EQUITY ↓Cumulative $331K1st Form D$331K

Latest events

  • Private capital raisedForm D · SEC · 1st filing$331K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#370 · top 33%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Abe SchwartzDirectorNamed in SEC Form D filings
  • Brian PedlarExecutive Officer, DirectorNamed in SEC Form D filings
  • Danny BrannaganExecutive OfficerNamed in SEC Form D filings
  • Gale PollockDirectorNamed in SEC Form D filings
  • Ian BrindleDirectorNamed in SEC Form D filings
  • Jeffrey MandelDirectorNamed in SEC Form D filings
Show all 11 people
  • John SukDirectorNamed in SEC Form D filings
  • Joseph CordianoDirectorNamed in SEC Form D filings
  • Myrna FrancisDirectorNamed in SEC Form D filings
  • Ron SmithDirectorNamed in SEC Form D filings
  • Val DitizioExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 3 granted of 7
Show all 7 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .